# Electronic Blood Pressure Monitor for Atrial Fibrillation Detection

Study · id `cardio:ct-nct06931288` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06931288](<https://clinicaltrials.gov/study/NCT06931288>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06931288

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 20000 participants.

## Technical summary

Registry record NCT06931288. Randomized; no masking; primary purpose screening. Start 2025-05-06 (anticipated); primary completion 2026-07-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 20000 participants (planned count; ClinicalTrials.gov record NCT06931288, source copy `cardio:ctgov-nct06931288-2025-04-17`, retrieved 2026-10-26)
- Planned start: 2025-05-06 (anticipated) (ClinicalTrials.gov record NCT06931288, source copy `cardio:ctgov-nct06931288-2025-04-17`, retrieved 2026-10-26)
- Primary completion: 2026-07-31 (anticipated) (ClinicalTrials.gov record NCT06931288, source copy `cardio:ctgov-nct06931288-2025-04-17`, retrieved 2026-10-26)
- Completion: 2026-07-31 (anticipated) (ClinicalTrials.gov record NCT06931288, source copy `cardio:ctgov-nct06931288-2025-04-17`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06931288, source copy `cardio:ctgov-nct06931288-2025-04-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06931288-2025-04-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Electronic Blood Pressure Monitor for Atrial Fibrillation Detection
- Condition: Atrial Fibrillation (AF)
- Intervention (Device): Blood pressure monitor
- Intervention (Device): Single-lead ECG
- Lead sponsor: Shanghai Jiao Tong University School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Shanghai Jiao Tong University School of Medicine (`cardio:org-shanghai-jiao-tong-university-school-of-medicine`)

## Provenance

Content hash: 24c33d7039ba6023a6d82128731fcd9f18e7cf408666bf5e068dbb349d3ef691
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
